Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Castration Resistant Prostate Cancer (mCRPC) × Lutetium × Genitourinary × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Urogenital Neoplasms 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1

Interventions

talazoparib 1 radium Ra 223 dichloride 1 olaparib 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 CX 5461 1 BAY 2315497 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06894511 2026-02-17

PSMAndARPI

Novartis

Phase 2 Active not recruiting

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡